State Street’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.94M Sell
801,323
-47,654
-6% -$396K ﹤0.01% 2971
2025
Q4
$8.85M Buy
848,977
+24,833
+3% +$249K ﹤0.01% 2712
2025
Q3
$7.41M Sell
824,144
-92,071
-10% -$808K ﹤0.01% 2806
2025
Q2
$11.9M Buy
916,215
+17,546
+2% +$264K ﹤0.01% 2483
2025
Q1
$22.7M Buy
898,669
+7,870
+0.9% +$234K ﹤0.01% 2070
2024
Q4
$30.6M Buy
890,799
+73,128
+9% +$3.3M ﹤0.01% 1971
2024
Q3
$40.4M Buy
817,671
+62,349
+8% +$3.19M ﹤0.01% 1810
2024
Q2
$45.4M Buy
755,322
+84,039
+13% +$4.8M ﹤0.01% 1723
2024
Q1
$34.6M Sell
671,283
-32,684
-5% -$1.6M ﹤0.01% 1917
2023
Q4
$28.4M Buy
703,967
+6
+0% +$176 ﹤0.01% 2008
2023
Q3
$19.6M Buy
703,961
+254,081
+56% +$7.58M ﹤0.01% 2186
2023
Q2
$13M Buy
449,880
+81,959
+22% +$1.82M ﹤0.01% 2502
2023
Q1
$6.14M Buy
367,921
+73,869
+25% +$1.04M ﹤0.01% 2916
2022
Q4
$3.73M Buy
294,052
+3,045
+1% +$37K ﹤0.01% 3170
2022
Q3
$3.49M Buy
291,007
+3,765
+1% +$51.7K ﹤0.01% 3233
2022
Q2
$4.04M Buy
287,242
+135,935
+90% +$1.79M ﹤0.01% 3197
2022
Q1
$1.87M Buy
151,307
+43,623
+41% +$524K ﹤0.01% 3593
2021
Q4
$1.21M Buy
107,684
+17,307
+19% +$208K ﹤0.01% 3767
2021
Q3
$1.15M Buy
+90,377
New +$1.24M ﹤0.01% 3750

Other funds holding RXST

State Street's RXST Position: Q1 2026 in Review

State Street reduced its RxSight (RXST) stake by 5.6% in Q1 2026, selling an estimated $396K and leaving 801,323 shares worth $4.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2971.

State Street first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $45.4M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • State Street held 801,323 shares of RxSight worth $4.94M as of Q1 2026.
  • State Street sold 47,654 RxSight shares in Q1 2026, an estimated $396K.
  • RxSight made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2971 holding.
  • State Street first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
  • State Street's RxSight position peaked at $45.4M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.